673 related articles for article (PubMed ID: 33169132)
1. Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets.
Li R; Li Y; Liang X; Yang L; Su M; Lai KP
Brief Bioinform; 2021 Mar; 22(2):1279-1290. PubMed ID: 33169132
[TBL] [Abstract][Full Text] [Related]
2. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
Liang X; Zhou R; Li Y; Yang L; Su M; Lai KP
Aging (Albany NY); 2021 Jun; 13(12):15785-15800. PubMed ID: 34176789
[TBL] [Abstract][Full Text] [Related]
4. Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19.
Huang Y; Yuan Y; Chen S; Xu D; Xiao L; Wang X; Qin W; Liu B
Front Immunol; 2022; 13():985781. PubMed ID: 36275701
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
6. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.
Zheng W; Wu H; Wang T; Zhan S; Liu X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058750
[TBL] [Abstract][Full Text] [Related]
7. Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets.
Ye Y; Huang Z; Chen M; Mo Y; Mo Z
Front Endocrinol (Lausanne); 2021; 12():802447. PubMed ID: 35178029
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics and
Qin J; Guo C; Yang L; Liang X; Jiao A; Lai KP; Yang B
Bioengineered; 2021 Dec; 12(2):12461-12469. PubMed ID: 34931923
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets.
Wang S; Gao H; Wang X; Ma X; Zhang L; Xing Y; Jia Y; Wang Y
Front Pharmacol; 2022; 13():874637. PubMed ID: 35571107
[No Abstract] [Full Text] [Related]
10. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M
BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175
[TBL] [Abstract][Full Text] [Related]
11. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
12. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
13. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
14. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
15. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
Wang M; Fu D; Yao L; Li J
Comb Chem High Throughput Screen; 2021; 24(2):294-305. PubMed ID: 32767929
[TBL] [Abstract][Full Text] [Related]
16. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related biotargets and network mechanisms of fucoidan against colorectal cancer: An integrated bioinformatic and experimental approach.
Liu J; Meng Y; Li B; Wang P; Wan X; Huang W; Li R
Int J Biol Macromol; 2022 Dec; 222(Pt A):1522-1530. PubMed ID: 36195230
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
19. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
Zheng W; Wu H; Liu C; Yan Q; Wang T; Wu P; Liu X; Jiang Y; Zhan S
Front Immunol; 2021; 12():707287. PubMed ID: 34394108
[TBL] [Abstract][Full Text] [Related]
20. Preclinical findings: The pharmacological targets and molecular mechanisms of ferulic acid treatment for COVID-19 and osteosarcoma
Pang G; Yi T; Luo H; Jiang L
Front Endocrinol (Lausanne); 2022; 13():971687. PubMed ID: 36204096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
